DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Vaniprevir is an investigational drug.
There have been 11 clinical trials for Vaniprevir. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2011.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, and Hepatitis A. The leading clinical trial sponsors are Merck Sharp & Dohme Corp. and [disabled in preview].
Recent Clinical Trials for Vaniprevir
|Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)||Merck Sharp & Dohme Corp.||Phase 1|
|Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)||Merck Sharp & Dohme Corp.||Phase 3|
|Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)||Merck Sharp & Dohme Corp.||Phase 3|